Director, Head and Neck Oncology
The Ohio State University Wexner Medical Center
Columbus, Ohio, United States
James W. Rocco. MD, PhD, FACS is currently Professor of Otolaryngology, and the Mary E. and John W. Alford Chair of Research in Head and Neck Cancer at the James Cancer Hospital/Solove Research Institute at the Ohio State University Wexner Medical Center. He is also the Director of the Division of Head and Neck Oncologic Surgery, Medical Director of the Head and Neck Service Line, and Co-Director of the Head and Neck Disease Specific Research Group. Dr. Rocco leads an active R01-funded research effort focused on identifying biomarkers of clinical outcome in head and neck squamous cell carcinoma and was the Principal Investigator of an NCI trial targeting blood vessel growth in patients with recurrent or metastatic disease. He serves on the NCI’s Head and Neck Steering Committee as an Expert Advisor, and as a member of the Recurrent and Metastatic Disease task force. Dr. Rocco is an active participant within the AHNS and AJCC, and serves on the College of American Pathologist’s task force on HPV testing standards, and the ASTRO task force on Oropharyngeal cancer therapeutic guidelines. Dr. Rocco serves on several editorial boards (JCO, Head and Neck, Oral Oncology) and is now an Associate Editor for the journal Head and Neck. He has published numerous peer-reviewed scientific and clinical manuscripts and has been interviewed extensively by the lay press regarding head and neck cancer on numerous occasions, including interviews for Forbes magazine, the Wall Street Journal, Nature and the Proceedings of the National Academy of Sciences. Dr. Rocco is committed to training the future leaders of Head and Neck Oncology. He actively mentors medical students, residents, post-docs, fellows and junior faculty. He serves on numerous thesis and advisory committees and regularly lectures graduate students on the molecular aspects of head and neck cancer.
Medicare Advantage Prior Authorization Requirements for Otolaryngologic Procedures
Monday, September 30, 2024
9:42 AM – 9:48 AM EDT
Disclosure information not submitted.